No Detail Found!

Erythrocyte Sedimentation Rate and C-reactive Protein as Marker of Acute Versus Chronic Medical Conditions.

Author(s)
Azmat Ali Medicine Department, KRL Hospital Islamabad, Pakistan
Awais Saeed Abbasi Medicine Department, KRL Hospital Islamabad, Pakistan
Tehrim Amjad Medicine Department, KRL Hospital Islamabad, Pakistan
Fyza Saleem Medicine Department, KRL Hospital Islamabad, Pakistan
Abstract
Background: The erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are frequently requested investigations that aid health professionals in precisely diagnosing and following a number of complicated disease conditions. The aim of this study is to ascertain whether a rise in any of these acute phase reactants has predilection for an acute illness versus chronic disease. Methods: Current study includes 144 patients admitted to Medical ward and Intensive care unit of Khan Research Laboratory (KRL) Hospital Islamabad from January to April 2017. ESR was measured using conventional Westergren method. CRP level (mg/L) was measured from venous or capillary blood using a point of care testing (POCT) device. SPSS version 20 was used for data analysis. Results: Out of 144 patients who participated in this study 60.5% (n=87) were males while 39.6% (n=57) were females. Mean age was 53.4±18.9 years. Among acute medical conditions, Pneumonia and Enteric fever were common 13.2% (n=12) each. Diabetes Mellitus (DM) with complications was the commonest chronic medical condition 22.6% (n=12). Thirty-two patients had ESR <15 mm/Hour; out of them 71.8% (n=23) had acute while 28.2% (n=9) had chronic medical conditions. Thirty-four patients had ESR =15 & <30 mm/Hour; out of them 52.9% (n=18) had acute while 47.1% (n=16) had chronic medical conditions. Seventy-eight patients had ESR =30 mm/Hour; out of them 64.1% (n=50) had acute while 35.9% (n=28) had chronic medical conditions. All results were statistically significant with p-value =0.05. 75 patients had CRP <10 mg/L; out of them 66.7% (n=50) had acute while 33.3% (n=25) had chronic medical conditions. Sixty-nine patients had CRP =10 & <100 mg/L; out of them 59.4% (n=41) had acute while 40.6% (n=28) had chronic medical conditions. All results were statistically significant with p-value =0.05. In acute medical conditions mean CRP was 16.8±17.7 mg/L and average ESR was 35.9±25.6 mm/Hour. In chronic medical conditions mean CRP was 16.3±17.2 mg/L and mean ESR was 40.8±32.5 mm/Hour. Conclusion: No difference was found between CRP and ESR as markers of acute versus chronic medical conditions. Both CRP and ESR have positive association with acute as well as chronic medical conditions. Elevated ESR was seen more frequently in acute medical conditions as compared to CRP.
Publication Details
Page(s) 39-45
DOI DOI not available
Published Journal: Journal of Ayub Medical College, Volume: 31, Issue: 1, Year: 2019

Request the full text from PASTIC

References
AhmedMS,JadhavAB,HassanA,MengQH, 2012.Acute Phase Reactants as Novel Predictors of Cardiovascular Disease,ISRN Inflamm 953461 -
BrayC,BellLN,LiangH,HaykalR,KaiksowF,MazzaJJ, 2016.Erythrocyte sedimentation rate and C-reactive protein measurements and their relevance in clinical medicine,WMJ 115 317 -21
TillettWS,FrancisT., 1930.Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus,J Exp Med 52 561 -71
KushnerI,SamolsD, 2011.Oswald Avery and the pneumococcus,Pharos Alpha Omega Alpha Honor Med Soc 74 14 -8
LitaoMK,KamatD., 2014.Erythrocyte sedimentation rate and Creactive protein: how best to use them in clinical practice,Pediatr Ann 43 417 -420
MarkandayA.,Acute, 2015.Phase Reactants in Infections: Evidence-Based review and a guide for clinicians,Open Forum Infect Dis 2 ofv098 -
BedellSE,BushBT, 1985.Erythrocyte sedimentation rate. From folklore to facts,Am J Med 78 1001 -9
BatlivalaSP., 2009.Focus on diagnosis: the erythrocyte sedimentation rate and the C-reactive protein test,Pediatr Rev 30 72 -4
OlshakerJS,JerrardDA, 1997.The erythrocyte sedimentation rate,J Emerg Med 15 869 -74
AhmedYF,AbbagFI,Al-QahtaniJM,GhazaliBM,AbolfotouhMA, 2000.Erythrocyte sedimentation rate during steady state, painful crisis and infection in children with sickle cell disease,Saudi Med J 21 461 -3
BrigdenML, 1999.Clinical utility of the erythrocyte sedimentation rate,Am Fam Physician 60 1443 -50
AmerioP,GirardelliCR,ProiettoG,ForleoP,CerritelliL,FelicianiC, 2002.Usefulness of erythrocyte sedimentation rate as tumor marker in cancer associated dermatomyositis,Eur J Dermatol 12 165 -9
MallyaRK,de BeerFC,BerryH,HamiltonED,MaceBE,PepysMB, 1982.Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate,J Rheumatol 9 224 -8
SbongS,FeldmanM. Frequency, 2015.and causes of C-reactive protein and erythrocyte sedimentation rate disagreements in adults,Int J Rheum Dis 18 29 -32
KushnerI., 1991.C-reactive protein in rheumatology,Arthritis Rheum 34 1065 -8
NestelAR, 2012.ESR changes with age--a forgotten pearl,BMJ 344 e1403 -9
MillerA,GreenM,RobinsonD., 1983.Simple rule for calculating normal erythrocyte sedimentation rate,Br Med 286 266 -
LeffRD,AkreSP, 1986.Obesity and the erythrocyte sedimentation rate,Ann Intern Med 105 143 -
CrowsonCS,RahmanMU,MattesonEL, 2009.Which measure of inflammation to use? A comparison of erythrocyte sedimentation rate and C-reactive protein measurements from randomized clinical trials of golimumab in rheumatoid arthritis,J Rheumatol 36 1606 -10
FiresteinGS,BuddRC,HarrisED,McInnesIB,RuddyS,SergentJS, 2009.Kelly's Textbook of Rheumatology, -
GabayC,KushnerI, 1999.Acute-phase proteins and other systemic responses to inflammation,N Engl J Med 340 448 -54
LevineMJ,McGuireKJ,McGowanKL,FlynnJM, 2003.Assessment of the test characteristics of C-reactive protein for septic arthritis in children,J Pediatr Orthop 23 373 -7
BrarNK,NiedermanMS, 2011.Management of communityacquired pneumonia: a review and update,Ther Adv Respir Dis 5 61 -78
CrumpJA,LubySP, 2004.The global burden of typhoid fever,Bull World Health Organ 82 346 -53
WhitingDR,GuariguataL,WeilC, 2011.Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030,Diabetes Res Clin Pract 94 311 -21
2011.,Global Tuberculosis Control: World Health Organization report -
Le GallC,Désidéri-VaillantC,NicolasX., 2011.Significations of extremely elevated C-reactive protein: about 91 cases in a French hospital center],Pathol Biol 59 319 -20
MarnellL,MoldC, 2005.Du Clos TW. C-reactive protein: ligands, receptors and role in inflammation,Clin Immunol 117 104 -11
FincherRM,PageMI., 1986.Clinical significance of extreme elevation of the erythrocyte sedimentation rate,Arch Intern Med 146 1581 -3
GaitondeS,SamolsD,KushnerI., 2008.C-reactive protein and systemic lupus erythematosus,Arthritis Rheum 59 1814 -20
KayJ,MorgachevaO,MessingSP,KremerJM,GreenbergJD,ReedGW, 2014.Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year,Arthritis Res Ther 16 R40 -
WackerC,PrknoA,BrunkhorstFM,SchlattmannP, 2013.Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis,Lancet Infect Dis 13 426 -35
WuJY,LeeSH,ShenCJ,HsiehYC,YoPH,ChengHY, 2012.Use of serum procalcitonin to detect bacterial infection in patients with autoimmune diseases: a systematic review and meta-analysis,Arthritis Rheum 64 3034 -42
0

Citations

0

Downloads

61

Views